An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) will present at two major healthcare conferences: the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference on January 6, 2022 at 11 a.m. ET and the J.P. Morgan 40th Annual Healthcare Conference on January 11, 2022 at 4:30 p.m. ET. Presentations will be made by CEO Mike McMullen and CFO Bob McMahon. Both events will be webcast, and further details can be found on Agilent's Investor Relations page. The company reported $6.32 billion in revenue for fiscal 2021.
Positive
None.
Negative
None.
SANTA CLARA, Calif.--(BUSINESS WIRE)--
Agilent Technologies Inc. (NYSE: A) today announced the company will deliver presentations at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference and the J.P. Morgan 40th Annual Healthcare Conference. Both conferences will be webcast. Details are included below.
J.P. Morgan 40th Annual Healthcare Conference
Date: Jan. 11, 2022 Time: 4:30 p.m. ET/1:30 p.m. PT Presenting for Agilent:
Mike McMullen, Agilent chief executive officer
Links to join the webcast will be available in the "News & Events -- Events" portion of the Investor Relations section of Agilent’s website.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward advancing the quality of life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.32 billion in fiscal 2021 and employs 17,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter and Facebook.